Related Experiment Video
Updated: Mar 28, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
MicroRNA expression profiles in pediatric dysembryoplastic neuroepithelial tumors
M Braoudaki1,2, G I Lambrou3, S A Papadodima4
1University Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, "Aghia Sophia" Children's Hospital, University of Athens, Athens, Greece. mbraoudak@med.uoa.gr.
Abstract:
Among noncoding RNAs, microRNAs (miRNAs) have been most extensively studied, and their biology has repeatedly been proven critical for central nervous system pathological conditions. The diagnostic value of several miRNAs was appraised in pediatric dysembryoplastic neuroepithelial tumors (DNETs) using miRNA microarrays and receiving operating characteristic curves analyses. Overall, five pediatric DNETs were studied. As controls, 17 samples were used: the FirstChoice Human Brain Reference RNA and 16 samples from deceased children who underwent autopsy and were not present with any brain malignancy. The miRNA extraction was carried out using the mirVANA miRNA Isolation Kit, while the experimental approach included miRNA microarrays covering 1211 miRNAs. Quantitative real-time polymerase chain reaction was performed to validate the expression profiles of miR-1909* and miR-3138 in all samples initially screened with miRNA microarrays. Our findings indicated that miR-3138 might act as a tumor suppressor gene when down-regulated and miR-1909* as a putative oncogenic molecule when up-regulated in pediatric DNETs compared to the control cohort. Subsequently, both miRNA signatures might serve as putative diagnostic biomarkers for pediatric DNETs.
Insights
MicroRNAs (miRNAs) show diagnostic value in pediatric dysembryoplastic neuroepithelial tumors (DNETs). miR-3138 may suppress tumors, while miR-1909* may promote them, serving as potential DNET biomarkers.
Area of Science:
- Neuroscience
- Molecular Biology
- Oncology
Background:
- MicroRNAs (miRNAs) are critical noncoding RNAs in central nervous system pathologies.
- Pediatric dysembryoplastic neuroepithelial tumors (DNETs) require reliable diagnostic markers.
Purpose of the Study:
- To evaluate the diagnostic value of specific miRNAs in pediatric DNETs.
- To identify potential miRNA biomarkers for DNET diagnosis.
Main Methods:
- miRNA microarrays analyzing 1211 miRNAs in five pediatric DNETs and 17 control samples.
- Quantitative real-time polymerase chain reaction (qRT-PCR) for validating miR-1909* and miR-3138 expression.
Main Results:
- miR-3138 was down-regulated in DNETs, suggesting a tumor suppressor role.
- miR-1909* was up-regulated in DNETs, indicating a potential oncogenic function.
- Distinct miRNA expression profiles were observed between pediatric DNETs and controls.
Conclusions:
- miR-3138 and miR-1909* signatures may serve as diagnostic biomarkers for pediatric DNETs.
- These findings contribute to understanding miRNA involvement in DNET pathogenesis.
Related Concept Videos
MicroRNAs
MicroRNAs

